# vomiting induced FDA approvals and PDUFA dates

Canonical: https://sec-api.dev/indications/vomiting-induced

> No upcoming FDA catalysts in vomiting induced; 2 past events are recorded.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: month only, exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Verified answer

### What are the upcoming FDA decisions for vomiting induced?

No upcoming FDA catalysts in vomiting induced; 2 past events are recorded. SEC Form 8-K: "On December 30, 2025, Vanda Pharmaceuticals Inc. issued a press release announcing that the U.S. Food and Drug Administration has approved NEREUSTM (tradipitant) for the prevention of vomiting induced by motion." [Calendar and source filings](https://sec-api.dev/indications/vomiting-induced)

Source: SEC Form 8-K, accession 0001628280-25-059155, https://www.sec.gov/Archives/edgar/data/1347178/000162828025059155/vnda-20251230.htm (retrieved 2026-11-12). Last confirmed 2026-02-12. Cite: https://sec-api.dev/indications/vomiting-induced#answer

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Dec 2023 | [NEREUSTM (tradipitant) FDA approval](https://sec-api.dev/pdufa/tradipitant) | VNDA | vomiting induced | completed, approved | "We have paid Lilly $5.0 million in upfront fees and development milestones, including a $2.0 million development milestone paid in December 2023 for the filing of the first marketing authorization for NEREUSTM in the U.S. or the E.U. In the fourth quarter of 2025, our NDA for the prevention of vomiting induced by motion was approved by the FDA and we accrued $10.0 million as a current liability as of December 31, 2025." ([SEC Form 10-K](https://www.sec.gov/Archives/edgar/data/1347178/000162828026007460/vnda-20251231.htm)) |
| December 30, 2025 | [NEREUSTM (tradipitant) FDA approval](https://sec-api.dev/pdufa/tradipitant) | VNDA | vomiting induced | completed, approved | "On December 30, 2025, Vanda Pharmaceuticals Inc. issued a press release announcing that the U.S. Food and Drug Administration has approved NEREUSTM (tradipitant) for the prevention of vomiting induced by motion." ([SEC Form 8-K](https://www.sec.gov/Archives/edgar/data/1347178/000162828025059155/vnda-20251230.htm)) |

## Drugs

- [NEREUSTM (tradipitant)](https://sec-api.dev/pdufa/tradipitant) (VNDA)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/indications/vomiting-induced.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "vomiting induced FDA approvals and PDUFA dates." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/indications/vomiting-induced

```bibtex
@misc{secapidev_indications_vomiting_induced_20261116,
  title        = {vomiting induced FDA approvals and PDUFA dates},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/indications/vomiting-induced}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_indications_vomiting_induced_20261116","title":"vomiting induced FDA approvals and PDUFA dates","publisher":"sec-api.dev","URL":"https://sec-api.dev/indications/vomiting-induced","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
